Congress to Mylan: Tell us more By: Pittsburgh Business Times via Business Journals October 04, 2016 at 08:23 AM EDT The controversy over pricing of the anti-allergy medication EpiPen continues to dog Canonsburg's Mylan NV (Nasdaq: MYL). Read More >>